369 related articles for article (PubMed ID: 26370353)
1. Consensus on biomarkers for neuroendocrine tumour disease.
Oberg K; Modlin IM; De Herder W; Pavel M; Klimstra D; Frilling A; Metz DC; Heaney A; Kwekkeboom D; Strosberg J; Meyer T; Moss SF; Washington K; Wolin E; Liu E; Goldenring J
Lancet Oncol; 2015 Sep; 16(9):e435-e446. PubMed ID: 26370353
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
Modlin IM; Bodei L; Kidd M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
[TBL] [Abstract][Full Text] [Related]
3. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells and miRNAs as prognostic markers in neuroendocrine neoplasms.
Zatelli MC; Grossrubatscher EM; Guadagno E; Sciammarella C; Faggiano A; Colao A
Endocr Relat Cancer; 2017 Jun; 24(6):R223-R237. PubMed ID: 28389504
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A: any relevance in neuroendocrine tumors?
Kidd M; Bodei L; Modlin IM
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):28-37. PubMed ID: 26627724
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs.
Rizzo FM; Meyer T
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):471-483. PubMed ID: 30098711
[TBL] [Abstract][Full Text] [Related]
7. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
8. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
Sumanasuriya S; Omlin A; Armstrong A; Attard G; Chi KN; Bevan CL; Shibakawa A; IJzerman MJ; De Laere B; Lolkema M; Lorente D; Luo J; Mehra N; Olmos D; Scher H; Soule H; Stoecklein NH; Terstappen LWMM; Waugh D; de Bono JS
Eur Urol Oncol; 2018 Jun; 1(2):151-159. PubMed ID: 31100240
[TBL] [Abstract][Full Text] [Related]
9. [Significance of biochemical markers in the diagnosis of neuroendocrine tumours and for the follow-up of patients].
Tőke J; Czirják G; Tóth M; Rácz K; Patócs A
Orv Hetil; 2014 Nov; 155(45):1775-82. PubMed ID: 25362640
[TBL] [Abstract][Full Text] [Related]
10. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.
Ardill JE; Erikkson B
Endocr Relat Cancer; 2003 Dec; 10(4):459-62. PubMed ID: 14713258
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours.
Barriuso J; Custodio A; Afonso R; Alonso V; Astudillo A; Capdevila J; García-Carbonero R; Grande E; Jimenez-Fonseca P; Marazuela M; Rodríguez-Antona C; Aller J
Cancer Treat Rev; 2018 Nov; 70():209-222. PubMed ID: 30292979
[TBL] [Abstract][Full Text] [Related]
12. ASO Author Reflections: Circulating Neuroendocrine Gene Transcripts (NETest): A Promising Biomarker for Pancreatic Neuroendocrine Tumours (PanNET).
Partelli S; Falconi M
Ann Surg Oncol; 2020 Oct; 27(10):3937-3938. PubMed ID: 32462530
[No Abstract] [Full Text] [Related]
13. Prognostic and predictive biomarkers in neuroendocrine tumours.
Chan DL; Clarke SJ; Diakos CI; Roach PJ; Bailey DL; Singh S; Pavlakis N
Crit Rev Oncol Hematol; 2017 May; 113():268-282. PubMed ID: 28427516
[TBL] [Abstract][Full Text] [Related]
14. Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Giannetta E; La Salvia A; Rizza L; Muscogiuri G; Campione S; Pozza C; Colao AAL; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():672499. PubMed ID: 34367064
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment options of neuroendocrine tumours].
Uhlyarik A; Pápai Z
Orv Hetil; 2013 Sep; 154(39):1549-55. PubMed ID: 24058100
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers.
Herrera-Martínez AD; Hofland LJ; Gálvez Moreno MA; Castaño JP; de Herder WW; Feelders RA
Endocr Relat Cancer; 2019 Mar; 26(3):R157-R179. PubMed ID: 30615596
[TBL] [Abstract][Full Text] [Related]
17. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
[TBL] [Abstract][Full Text] [Related]
18. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
Malczewska A; Kidd M; Matar S; Kos-Kudła B; Bodei L; Oberg K; Modlin IM
Neuroendocrinology; 2020; 110(3-4):198-216. PubMed ID: 31266019
[TBL] [Abstract][Full Text] [Related]
19. Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status.
Kidd M; Drozdov I; Modlin I
Endocr Relat Cancer; 2015 Aug; 22(4):561-75. PubMed ID: 26037279
[TBL] [Abstract][Full Text] [Related]
20. Raised circulating Neurokinin A predicts prognosis in metastatic small bowel neuroendocrine tumours. Lowering Neurokinin A indicates improved prognosis.
Ardill JE; McCance DR; Stronge WV; Johnston BT
Ann Clin Biochem; 2016 Mar; 53(Pt 2):259-64. PubMed ID: 26038607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
